Get the detailed quarterly/annual income statement for Arbutus Biopharma Corporation (ABUS). Find out the revenue, expenses and profit or loss over the last fiscal year.

While Abus’s slippery Gamechanger is a popular choice among watt-chasing pros, the new Airbreaker 2.0, despite a name that suggests similar goals, has separate objectives. Namely, light weight, decent ...

Joe Pyfer was confident in his ground game and it eventually paid off at UFC 320. Pyfer (15-3 MMA, 6-1 UFC) dropped Abus Magomedov (28-7-1 MMA, 4-3 UFC) then submitted him with a rear-naked choke at ...

The UFC 320 Main Card opens with a massive Middleweight tilt! Check out our UFC odds series for the Pyfer-Magomedov prediction and pick. Joe Pyfer (14-3) has gone 5-1 since arriving to the UFC through ...

Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. The latest update is out from Arbutus ...

This piece first appeared in the June edition of BikeBiz magazine – not subscribed? Get a free subscription. What goes into making a helmet? Passion, determination, teamwork? It’s easy to forget how ...

Arbutus Biopharma (ABUS) came out with quarterly earnings of $0.01 per share, beating the Zacks Consensus Estimate of a loss of $0.02 per share. This compares to a loss of $0.11 per share a year ago.

LAS VEGAS, NEVADA - FEBRUARY 10: (L-R) Joe Pyfer punches Jack Hermansson of Sweden in a middleweight fight during the UFC Fight Night event at UFC APEX on February 10, 2024 in Las Vegas, Nevada.

Abus has updated its Airbreaker helmet, saying the Airbreaker 2.0 combines good ventilation with aerodynamics, borrowing its basic structure from the brand’s aero Gamechanger helmet. New features ...

Magomedov (27-6-1 MMA, 3-2 UFC) aims to make it three straight. The Russian middleweight enters on the heels of a perfect 2024 campaign where he defeated Warlley Alves and Brunno Ferreira. In just his ...